Trump To Sign Order To Pay TSA Agents Authored by Jacki Thrapp via The Epoch Times (emphasis ours), President Donald Trump plans to sign an order that will pay Transportation Security Administration (TSA) agents who have not received a check since the Department of Homeland Security (DHS) entered a partial shutdown in mid-February. “I am going to sign an Order instructing the Secretary of Homeland...
Trump To Sign Order To Pay TSA Agents Authored by Jacki Thrapp via The Epoch Times (emphasis ours), President Donald Trump plans to sign an order that will pay Transportation Security Administration (TSA) agents who have not received a check since the Department of Homeland Security (DHS) entered a partial shutdown in mid-February. “I am going to sign an Order instructing the Secretary of Homeland Security, Markwayne Mullin, to immediately pay our TSA Agents in order to address this Emergency Situation, and to quickly stop the Democrat Chaos at the Airports,” Trump wrote in a Truth Social post on March 26. More than 3,120 TSA agents, who haven’t been paid in weeks, called out on Wednesday, which prompted long lines to continue at airports across the country, according to a statement the DHS shared with The Epoch Times. “ It is not an easy thing to do, but I am going to do it! “ Trump added. ”I want to thank our hardworking TSA Agents and also, ICE, for the incredible help they have given us at the Airports.” Trump has blamed the Democrats for keeping DHS shut down, while Democrats have pushed for changes to immigration enforcement operations as a condition for funding the department. On March 25, Senate Democrats blocked funding for DHS in a 54–46 vote after Republicans rejected a counteroffer they put forward. On the same day, Democrats separately offered a standalone bill that would immediately fund TSA, but not ICE and Customs and Border Protection. Republicans blocked the proposal. This is a breaking story and will be updated. Tyler Durden Thu, 03/26/2026 - 20:10
Anthropic PBC is considering going public as soon as in October, according to people familiar with the matter, as the artificial intelligence company races with rival OpenAI Inc. to hold an initial public offering. The maker of the popular Claude chatbot has had early discussions with Wall Street banks about taking leading roles on a potential listing, the people said, asking not to be identified ...
Anthropic PBC is considering going public as soon as in October, according to people familiar with the matter, as the artificial intelligence company races with rival OpenAI Inc. to hold an initial public offering. The maker of the popular Claude chatbot has had early discussions with Wall Street banks about taking leading roles on a potential listing, the people said, asking not to be identified as the information isn’t public. Goldman Sachs Group Inc. , JPMorgan Chase & Co. and Morgan Stanley are expected to be under consideration for key roles on Anthropic and OpenAI’s listings, some of the people said. The Information reported earlier on the timing of Anthropic’s IPO. A listing could raise more than $60 billion, according to the report. Deliberations are ongoing and no final decisions have been made, the people said. Representatives for Anthropic and Goldman Sachs declined to comment. Spokespeople for OpenAI, JPMorgan and Morgan Stanley didn’t immediately respond to requests for comment. Anthropic was valued at $380 billion in a $30 billion funding round co-led by MGX that closed in February. It has partnerships with Alphabet Inc. ’s Google, Amazon.com Inc. , Microsoft Corp. and Nvidia Corp. These established firms have taken stakes in the AI startup, and have given Anthropic specialized chips and other technology in deals worth tens of billions of dollars. For the latest news on equity capital markets activity in the US, Canada and Latin America, follow the channel or visit NI BFWECMUS . To subscribe to ECM Watch , Bloomberg’s daily roundup of news from around the region, click here . Founded in 2021 by former OpenAI staffers including Chief Executive Officer Dario Amodei , Anthropic has aimed to be a more responsible AI steward than its competitors. Claude and its underlying technology have gained traction with enterprise customers in sectors like finance and health care, as well as with developers. Anthropic has pledged to spend $50 billion to build custom da...
Chinese Commerce Minister Wang Wentao raised “serious concerns” with US Trade Representative Jamieson Greer over new trade investigations, even as both sides signal a desire to stabilize relations before an expected presidential summit. In a meeting Thursday in Cameroon, Wang challenged Section 301 probes into China’s industrial overcapacity and alleged failure to ban forced-labor products, the Mi...
Chinese Commerce Minister Wang Wentao raised “serious concerns” with US Trade Representative Jamieson Greer over new trade investigations, even as both sides signal a desire to stabilize relations before an expected presidential summit. In a meeting Thursday in Cameroon, Wang challenged Section 301 probes into China’s industrial overcapacity and alleged failure to ban forced-labor products, the Ministry of Commerce said in a statement . These investigations are part of President Donald Trump ’s revived tariff strategy following a Supreme Court ruling that invalidated previous duties. Read More: US Starts Trade Probe Into China, EU as Trump Revives Duties The exchange took place on the sidelines of the 14th WTO Ministerial Conference. The Chinese objection to the investigations highlights a potential source of friction in relations, although both nations appear keen to advance plans for a face-to-face meeting between Trump and Xi. Wang cited Chinese President Xi Jinping and described trade as the “ballast” of the relationship. He urged the US to avoid “vicious competition” and implement the consensus reached during the leaders’ previous meeting in Busan and subsequent calls. The White House said this week Trump will visit Beijing May 14-15 following a delay due to the US war with Iran. China has yet to officially confirm those dates, typically waiting until closer to the event to announce leadership movements. Read More: Trump to Travel to China on May 14-15 for Summit With Xi
Earnings Call Insights: Insight Molecular Diagnostics Inc. (IMDX) Q4 2025 Management View CEO Joshua Riggs announced the submission of GraftAssureDx to the FDA, emphasizing, “we are, to our knowledge, the first dd-cfDNA assay to be submitted to the FDA for authorization.” Riggs detailed a shift in company focus toward product launch and commercialization, stating the company is accelerating adopti...
Earnings Call Insights: Insight Molecular Diagnostics Inc. (IMDX) Q4 2025 Management View CEO Joshua Riggs announced the submission of GraftAssureDx to the FDA, emphasizing, “we are, to our knowledge, the first dd-cfDNA assay to be submitted to the FDA for authorization.” Riggs detailed a shift in company focus toward product launch and commercialization, stating the company is accelerating adoption plans post-authorization. He highlighted strong engagement with transplant centers: “Since we announced the registry in the fall, we've had 28 centers start the process to become a trial site. That's over halfway to our goal of 50 in a very short period of time.” Riggs noted strategic investments in clinical, technical sales, and medical affairs headcount to drive engagement and awareness. Early head-to-head data was described as pivotal, with a major transplant center presenting “preliminary data showing that they could get equivalent results to one of the national reference labs using our GraftAssure technology.” CEO Riggs also outlined 2026 goals, including launching GraftAssure research use only, marketing GraftAssure core, and driving samples to their Tennessee lab. Additional initiatives include submitting GraftAssure for approval in the U.K. and EU, and pivoting R&D to heart transplant testing. CFO Andrea James stated, “we are preparing to do two focus things. First, we intend to commercialize and begin scaling that kidney transplant assay. And so accordingly, we're making controlled investments in sales and marketing to do that. And second, we intend to maintain our product development momentum by expanding GraftAssure into heart transplant testing.” She reported completion of a $26 million offering and ongoing disciplined investment, adding, “maintenance spending is about $5.5 million per quarter, and our growth spending is about $2 million per quarter.” James highlighted a $2 billion annual total addressable market and discussed updated Medicare reimbursement f...